CAS: 39499-34-8; 5-Methylisoxazole-3-Carbonyl Chloride

该化合物是一种化学化合物,其特点是异氧环结构,这是一个由五人组成的含有氮和氧原子的热循环化合物,该化合物具有碳基氯化物功能组,使其成为反应性丙基氯,它通常用于有机合成,特别是用于制作各种衍生物和开发药品; 异氧环的5位置的甲基组的存在,可以影响其再活动性和溶解性; 作为一种丙基氯化烷,已知它会与包括酒精和阿明斯在内的核分裂物分别形成酯和氨,该化合物可能对湿气敏感,应当谨慎处理,因为它能释放盐酸,因此在水解过程中可以释放.

结构式图片

相似化合物

62254-74-4 35166-37-1 24068-54-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

5-methyl-isoxazole-3-carboxylic acid; sodium salt 5-methylisoxazole 3-carboxylic acid ethyl 5-methylisoxazole-3-carboxylate 5-methyl-isoxazole-3-carboxylic acid dimethylamide 5-methyl-3-(N-phenylcarbamoyl)isoxazole 5-methyl-isoxazole-3-carbothioic acid amide H-pyrazole3,5-dimethyl-1-(5-methyl-isoxazole-3-carbonyl)-1H-pyrazole

合成工艺路线路线简述

    5-甲基异恶唑-3-甲酸置于氯化亚砜体系中,用 六甲基磷酰三胺,乙腈 作为反应溶剂,化学反应 0.5H,反应生成 5-甲基异恶唑-3-羰酰氯
    参考文献:融合的咪唑并吡啶的合成与构效关系:一系列苯二氮杂ze受体配体
    标题:融合的咪唑并吡啶的合成与构效关系:一系列苯二氮杂ze受体配体
    摘要:合成了2-Arylimidazo [4,5-C]喹啉和类似的稠合咪唑并吡啶,并评价为苯并二氮杂receptor受体配体.与吡唑并喹啉如cgs-9896相比,与受体的亲和力受2-位芳基庞大性的影响.在2-位具有异恶唑部分的衍生物显示出高结合亲和力和体内活性.在咪唑并[4,5-C]喹啉系列中,在6-位的取代降低或消除了活性.除7-卤代类似物外,大多数具有未取代异恶唑基的衍生物均表现出拮抗或反向激动剂活性.另一方面,5-甲基异恶唑-3-基或3-甲基异恶唑-5-基衍生物通常表现出激动剂活性.在与非芳族环稠合的咪唑并吡啶中观测到对异恶唑部分的类似取代作用.根据详细的药理评估,S-8510,2-(3-异恶唑基)-3,6,7,9-四氢咪唑并[4,5-D]吡喃++ + [4,3-B]吡啶一磷酸具有弱的反向激动剂选择活性作为治疗老年性痴呆某些症状的治疗候选药物.
    DOI:10.1021/jm9600609

    海关参考信息

    专利信息


    专利号:US-6534530-B1
    优先权日:1999-08-04
    标题:Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
    发明人:DRAGOVICH PETER SCOTT; ZHOU RU; WEBBER STEPHEN EVAN; PRINS THOMAS J; REICH SIEGFRIED HEINZ; KEPHART SUSAN E; RUI YUANJIN
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula:where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

    专利号:US-6514997-B2
    优先权日:1999-12-03
    标题:Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
    发明人:DRAGOVICH PETER S; PRINS THOMAS J; ZHOU RU; JOHNNSON JR THEODORE O
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula: n where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the picornaviral 3C protease. Also disclosed are compounds of the formula: n where the formula variables are as defined herein that advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as rhinovirus 3C proteases. Intermediates and synthetic methods for preparing such compounds are also described.

    专利号:US-6995142-B2
    优先权日:1998-04-30
    标题 :Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
    发明人:DRAGOVICH PETER SCOTT; WEBBER STEPHEN EVAN; PRINS THOMAS JAY; ZHOU RU; MARAKOVITS JOSEPH TIMOTHY; JOHNSON JR THEODORE O
    权利人:AGOURON PHARMA
    摘要:Peptido and peptidomimetic compounds of the formula: n nwherein the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also provided.
    南京新斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nstbio.com
    企业联系电话:025-85331029,18915981017👤
    📞南京新斯特生物科技有限公司 ⚠️参考联系方式
    联系人:杨女士
    电话:025-85331029,18915981017
    手机:18915981017
    传真:025-85331829
    邮箱:sales@nstbio.com
    通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    邮编: 210010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11426-011-4478-5
    摘要:Lin D, Qian W, Hilgenfeld R, Jiang H, Chen K, Liu H. Improved synthesis of rupintrivir. Science China Chemistry. 2012 Jan 04;55(6):1101–7. doi: 10.1007/s11426-011-4478-5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知